Links to 9 New HCV Abstracts

[Guest guest]

GB virus C infection among young, HIV–negative injection drug users with and

without hepatitis C virus infection

Journal of Viral Hepatitis

Detection of bacterial DNA in serum and ascitic fluid of asymptomatic

outpatients with cirrhosis and non–neutrocytic ascites

Liver International

Serum lipids and their associations with viral levels and liver disease severity

in a treatment–naïve chronic hepatitis C type 1–infected cohort

Journal of Viral Hepatitis

Hepatitis C virus infection during pregnancy and the newborn period – are they

opportunities for treatment

Journal of Viral Hepatitis

Ribavirin plasma concentration is a predictor of sustained virological response

in patients treated for chronic hepatitis C virus genotype 2/3 infection

Journal of Viral Hepatitis

Hepatitis C Prevalence Among HIV–Positive MSM in San Francisco: 2004 and 2008

Sexually Transmitted Diseases

Measuring the incidence, prevalence and genetic relatedness of hepatitis C

infections among a community recruited sample of injecting drug users, using

dried blood spots

Journal of Viral Hepatitis

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial

Journal of Viral Hepatitis

Controlled release recombinant human interferon–alpha2b for treating patients

with chronic hepatitis C genotype 1: a phase 2a clinical trial

Journal of Viral Hepatitis

[Guest guest]

GB virus C infection among young, HIV–negative injection drug users with and

without hepatitis C virus infection

Journal of Viral Hepatitis

Detection of bacterial DNA in serum and ascitic fluid of asymptomatic

outpatients with cirrhosis and non–neutrocytic ascites

Liver International

Serum lipids and their associations with viral levels and liver disease severity

in a treatment–naïve chronic hepatitis C type 1–infected cohort

Journal of Viral Hepatitis

Hepatitis C virus infection during pregnancy and the newborn period – are they

opportunities for treatment

Journal of Viral Hepatitis

Ribavirin plasma concentration is a predictor of sustained virological response

in patients treated for chronic hepatitis C virus genotype 2/3 infection

Journal of Viral Hepatitis

Hepatitis C Prevalence Among HIV–Positive MSM in San Francisco: 2004 and 2008

Sexually Transmitted Diseases

Measuring the incidence, prevalence and genetic relatedness of hepatitis C

infections among a community recruited sample of injecting drug users, using

dried blood spots

Journal of Viral Hepatitis

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial

Journal of Viral Hepatitis

Controlled release recombinant human interferon–alpha2b for treating patients

with chronic hepatitis C genotype 1: a phase 2a clinical trial

Journal of Viral Hepatitis

[Guest guest]

GB virus C infection among young, HIV–negative injection drug users with and

without hepatitis C virus infection

Journal of Viral Hepatitis

Detection of bacterial DNA in serum and ascitic fluid of asymptomatic

outpatients with cirrhosis and non–neutrocytic ascites

Liver International

Serum lipids and their associations with viral levels and liver disease severity

in a treatment–naïve chronic hepatitis C type 1–infected cohort

Journal of Viral Hepatitis

Hepatitis C virus infection during pregnancy and the newborn period – are they

opportunities for treatment

Journal of Viral Hepatitis

Ribavirin plasma concentration is a predictor of sustained virological response

in patients treated for chronic hepatitis C virus genotype 2/3 infection

Journal of Viral Hepatitis

Hepatitis C Prevalence Among HIV–Positive MSM in San Francisco: 2004 and 2008

Sexually Transmitted Diseases

Measuring the incidence, prevalence and genetic relatedness of hepatitis C

infections among a community recruited sample of injecting drug users, using

dried blood spots

Journal of Viral Hepatitis

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial

Journal of Viral Hepatitis

Controlled release recombinant human interferon–alpha2b for treating patients

with chronic hepatitis C genotype 1: a phase 2a clinical trial

Journal of Viral Hepatitis

[Guest guest]

GB virus C infection among young, HIV–negative injection drug users with and

without hepatitis C virus infection

Journal of Viral Hepatitis

Detection of bacterial DNA in serum and ascitic fluid of asymptomatic

outpatients with cirrhosis and non–neutrocytic ascites

Liver International

Serum lipids and their associations with viral levels and liver disease severity

in a treatment–naïve chronic hepatitis C type 1–infected cohort

Journal of Viral Hepatitis

Hepatitis C virus infection during pregnancy and the newborn period – are they

opportunities for treatment

Journal of Viral Hepatitis

Ribavirin plasma concentration is a predictor of sustained virological response

in patients treated for chronic hepatitis C virus genotype 2/3 infection

Journal of Viral Hepatitis

Hepatitis C Prevalence Among HIV–Positive MSM in San Francisco: 2004 and 2008

Sexually Transmitted Diseases

Measuring the incidence, prevalence and genetic relatedness of hepatitis C

infections among a community recruited sample of injecting drug users, using

dried blood spots

Journal of Viral Hepatitis

Hepatitis C treatment among racial and ethnic groups in the IDEAL trial

Journal of Viral Hepatitis

Controlled release recombinant human interferon–alpha2b for treating patients

with chronic hepatitis C genotype 1: a phase 2a clinical trial

Journal of Viral Hepatitis